Earlier this year, the American Association of Cancer Research (AACR) partnered with Novocure, a global oncology company, to launch several new funding initiatives to support innovative research focused on Tumor Treating Fields (TTFields).
Jan 1, 2019 | aacr.orgNovoCure Ltd. (NASDAQ: NVCR) today announced the 4 th Annual AACR-Novocure Grants for Tumor Treating Fields Research Program.
Jan 1, 2021 | biospace.comFollowing suit, NovoCure announced that ground has been broken on a new facility in Portsmouth, New Hampshire.
Jan 1, 2022 | biospace.comToday, Governor Chris Sununu (R-NH) joined Novocure for a ceremonial event commemorating the start of construction of its new flagship facility in the heart of downtown Portsmouth, New Hampshire.
Jan 1, 2022 | yahoo.com[ EIN PressWire June 21, 2022 ] xCures, Inc., is proud to announce their partnership with Novocure with the intent to develop the first comprehensive, longitudinal Quality of Life (QoL) dataset for glioblastoma (GBM) patients.
Jan 1, 2022 | xcures.comNovoCure has maintained a large amount of institutional and insider investors since IPO in 2015.
Sep 7, 2022 | tradetoday.co.inNovocure (NASDAQ: NVCR) today announced the creation of its U.S. CNS (central nervous system) Cancers Franchise.
Sep 21, 2022 | businesswire.comNovoCure named Frank Leonard, the company’s chief product officer, to lead the new effort.
Sep 23, 2022 | biospace.comWhen Ashley Cordova was promoted to chief financial officer of the cancer treatment company Novocure Ltd., she was the only C-level executive there who was a woman.
Dec 5, 2022 | bloomberglaw.com